Welcome to Sott.net
Mon, 06 Dec 2021
The World for People who Think

Health & Wellness
Map

Stock Up

WHO: Tuberculosis deaths increased in 2020 for first time in more than a decade

WHO Logo
© Getty Images
Global tuberculosis deaths saw an uptick in 2020 for the first time in more than a decade, a World Health Organization (WHO) report released Thursday found, attributing the rise to the disruption from the COVID-19 pandemic.

WHO documented about 1.5 million tuberculosis deaths last year, including 214,000 among people who were positive for HIV, an increase from 1.4 million tuberculosis deaths in 2019, when 209,000 HIV-positive people died from the disease.

The 5.6 percent increase in fatalities last year represented the first increase since 2005, with WHO predicting tuberculosis cases and deaths will rise "much higher" in 2021 and 2022. Experts expect tuberculosis to have been the second-leading cause of death from a single infectious agent last year, behind COVID-19, after ranking 13th in 2019.

"Far fewer" people received tuberculosis diagnoses and treatments last year, with an 18 percent reduction in diagnoses and a 21 percent decrease in people seeking preventive treatment in 2020.

The international health organization projects that about 4.1 million people currently have tuberculosis without a diagnosis, more than the 2019 prediction that 2.9 million unknowingly suffer from it.

Spending worldwide on tuberculosis diagnosis, treatment and prevention dwindled in 2020 from $5.8 billion to $5.3 billion, which WHO noted is less than half the 2022 target for tuberculosis spending.

Red Pill

Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

israeli hospital
© YONATAN SINDEL/FLASH90
Shaare Zedek hospital team members wearing safety gear work in the Coronavirus ward of Shaare Zedek hospital in Jerusalem on September 23, 2021.
Over-the-counter aspirin could protect the lungs of COVID-19 patients and minimize the need for mechanical ventilation, according to new research at the George Washington University.

The team investigated more than 400 COVID patients from hospitals across the United States who take aspirin unrelated to their COVID disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.

"As we learned about the connection between blood clots and COVID-19, we knew that aspirin - used to prevent stroke and heart attack - could be important for COVID-19 patients," said Dr. Jonathan Chow of the study team. "Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death."

Low-dose aspirin is a common treatment for anyone suffering from blood clotting issues or in danger of stroke, including most people who had a heart attack or a myocardial infarction. Although affecting the respiratory system, the coronavirus has been associated with small blood vessel clotting, causing tiny blockages in the pulmonary blood system, leading to ARDS - acute respiratory distress syndrome.

Comment: Covid-19 is in all likelihood a blood vessel disease, not primarily respiratory, so this makes sense. As for aspirin, it is part of the FLCCC's prevention and early outpatient treatment protocol for COVID-19. Prophylaxis and early treatment are what are needed to beat this virus. And they just happen to be the very things medical authorities are discouraging doctors and the general public from doing, causing needless deaths in the process.

UPDATE: This didn't take long:




Arrow Down

The data is in: We are now worse off than before the experimental jabs

Covid Vaccination
© Nathan Papes/The Springfield News-Leader via AP, File
About 68 percent of adults have received at least one shot of COVID vaccine in the US.
In October 2018, the Johns Hopkins Bloomberg School of Public Health published a report that, if one didn't know better, might make readers think the authors were involved in the gain-of-function research that likely created this virus. The report, titled "Technologies to Address Global Catastrophic Biological Risks," offers novel social control and mRNA vaccination ideas to deal with emerging pandemics "whether naturally emerging or reemerging, deliberately created and released, or laboratory engineered and escaped — that could lead to sudden, extraordinary, widespread disaster beyond the collective capability of national and international organizations and the private sector to control."

One of the many bone-chilling sections in this publication (pp. 45-47) provides a blueprint for "self-spreading vaccines," described as vaccines "genetically engineered to move through populations in the same way as communicable diseases, but rather than causing disease, they confer protection."

Comment:


Igloo

Benefits of sauna and winter-swimming revealed in new study on Scandinavian men

cold therapy water
© Unsplash/CC0 Public Domain
The Scandinavian winter swimming culture combines brief dips in cold water with hot sauna sessions — and now, a study of young men who participate regularly in these polar plunges finds that winter swimming may allow the body to adapt to extreme temperatures. The findings, publishing October 11 in the journal Cell Reports Medicine, suggest that routinely alternating swims or dips in chilly water with sauna sessions might affect how brown fat, also known as brown adipose tissue (BAT), burns energy and produces heat.

"Our data underscore that BAT in adult humans is part of the collective body temperature regulation system in collaboration with skeletal muscle and blood flow," says senior study author Camilla Scheele of the University of Copenhagen. "Regular winter swimming combining cold dips with hot sauna might be a strategy to increase energy expenditure, which could result in weight loss if compensatory increase in food intake can be avoided."

Comment: For more on the many benefits of sauna and cold adaptation, see: Also check out SOTT radio's:


SOTT Logo Radio

Objective:Health - Is October 15th Worldwide Mandatory Vaccination Day?

O:H header
Looking through the latest news, we can't help but notice the date October 15 being brought up repeatedly in the context of mandatory vaccinations. Italy's Green Pass is coming into force on October 15 and it's also the deadline for US Federal contract employees to get the vax, for example.

But it's not just at the federal level - many states, counties, universities and employers have taken on this seemingly arbitrary date as the deadline for vaccination - the drop dead date, if you will.

So what's the deal with October 15th? Coincidence? Is this just pattern recognition run amok, or is there something significant about this date? Because it's so widespread, is this an order coming from on high? Did the elites want everyone vaccinated on the first Friday after Canadian Thanksgiving? Or two weeks before Halloween?

Join us on this episode of Objective:Health as we speculate and hypothesize about what the heck is going on with October 15th.


And check us out on Brighteon!

For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥LBRY: https://lbry.tv/@objectivehealth:f
♥Odysee: https://odysee.com/@objectivehealth:f

And you can check out all of our previous shows (pre YouTube) here:

https://docs.google.com/spreadsheets/d/16H-nK-N0ANdsA5JFTT12_HU5nUYRVS9YcQh331dG2MI/edit?usp=sharing

Running Time: 00:36:14

Download: MP3 — 33.2 MB


Eye 1

Merck asks FDA for emergency approval of new COVID drug despite safety concerns

MERCK virus
© MERCK/Britannica.com/KJN
Despite warnings from scientists that its new COVID drug could have seriously harmful side effects like causing cancers and birth defects, Merck officially submitted the drug, Molnupiravir, to the FDA for approval. If it's approved, it would be the first antiviral pill to treat the virus.

According to the NYT, the drug would revolutionize COVID treatment since it would be able to relatively inexpensively treat many more high-risk patients sick with COVID, especially those that haven't been vaccinated (the drug was only tested on patients who hadn't been vaccinated). Still, the drug will be a cash cow for Merck, since Merck is planning to charge customers 40x the cost to make the drug.

Despite the price, countries are lining up for deals with Merck even before the drug has been approved. Merck has struck deals with the US government, as well as South Korea, Singapore, Malaysia, Australia and others.

The $700 course of the pill is meant to be taken at home as four capsules twice a day for five days, constituting a total of 40 pills. Per the trial data released by Merck - which was greeted with fawning from doctors and scientists - it halved hospitalizations and deaths (though the trial was cut short by a supervisory board who claimed the data was so positive it would be unethical to withhold the drug from the placebo group). The approval could come within weeks, per the NYT.

Comment: See also: Ivermectin is safer, and just as effective - probably more.


Bullseye

Making the case: A natural immunity cheat sheet

covid vaccine protest
There's a lot we don't know about the current state of the pandemic. What we can say for almost certain now is that if you had Covid and recovered your immune system has all the tools it needs to combat the disease going forward. Marty Makary from Johns Hopkins University put it this way:

"During every month of this pandemic, I've had debates with other public researchers about the effectiveness and durability of natural immunity," he wrote in an Op-Ed for U.S. News & World Report in August.
"I've been told that natural immunity could fall off a cliff, rendering people susceptible to infection. But here we are now, over a year and a half into the clinical experience of observing patients who were infected, and natural immunity is effective and going strong, and that's because with natural immunity, the body develops antibodies to the entire surface of the virus, not just a spike protein constructed from a vaccine."

Syringe

Steve Kirsch: 'At least 200,000 people have died from the Covid jabs in the US'

american vaccinated
Yesterday, October 8, 2021, I published a Highwire exclusive interview with Deborah Conrad, a physician's assistant who is blowing the whistle on COVID jab injuries, and the fact that these injuries are rarely reported because of a faulty VAERS database design.

Today you're in for yet another bombshell video: "Vaccine Secrets: COVID Crisis." It's the first episode of "The False Narrative Takedown Series," produced by Steve Kirsch, executive director of the COVID-19 Early Treatment Fund.

"Vaccine Secrets" complements and supports everything Conrad shared in her interview, so I highly recommend saving these files on your computer and watching both of them. Both are available on Bitchute.

Comment: 200K strikes us as too high a guesstimate. There could well be that many deaths-by-Covid-vaxx globally, but for the US alone it's probably more like 20K.

See also:


Syringe

VAERS data show COVID vaccine serious injury close to 112,000, Pfizer asks FDA for approval to inject kids 5 to 11

Covid vaccine
VAERS data released Friday by the CDC included a total of 778,685 reports of adverse events from all age groups following COVID vaccines, including 16,310 deaths and 111,921 serious injuries between Dec. 14, 2020 and Oct. 1, 2021.

Red Pill

Ivermectin: Truth & totalitarianism - Calling out the lie

ivermectine
"Merck stock surged 10% Friday after it said its investigational pill cuts the risk of hospitalization and death in COVID-19 patients...The pill reduced the risk of hospitalization or death by about 50%," Merck and its partner, Ridgeback Biotherapeutics, said in a statement Friday.

"This is a phenomenal result. This is a profound game-changer to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high risk who are already symptomatic," former FDA Commissioner Scott Gottlieb said Friday on CNBC about results of the interim analysis.
"Meanwhile, shares of COVID vaccine makers Pfizer and Moderna fell 2.5% and 10%, respectively."
This puts Dr. Scott Gottlieb between a rock and a hard place. On the one hand, as a member of Pfizer's Board of Directors, he is paid handsomely to attend a few board meetings per year, yet on the other hand, he must not be too glowing in his praise of the antiviral, which might lead people away from the Pfizer vaccine. Moreover, it could affect sales just as it has already dropped the stock price.

In 2020, Gottlieb was paid $338,587 by Pfizer. In 2020, he also earned $525,850 as a director of Illumina. Due to his former FDA Chief status, Gottlieb is in high demand as one word of favor from him can send a stock price soaring.

He has served on multiple other boards, including Tempus Labs, National Resilience, and the Mount Sinai Health System. It must be a daunting task to walk the line by promoting one corporate interest while not offending any of the others.